IDH1 and central nervous system cancer: These changes were also seen in the ex vivo setting, where organotypic slices were generated from a post-treatment recurrent GBM (Fig. 2c) and a high-grade R132H IDH1 mutated glioma (Fig. 2d) with neighboring slices being placed into either control media or CMD media.